July 12, PharmAust and WEHI Investigate Monepantel in HTLV-1 infection
210712_PharmAust and WEHI Investigate Monepantel in HTLV-1
July 9, PharmAust ANZCVS Science Week Presentation
210709_Science Week Slides
July 7, Update on Ongoing MPL GMP Tablet Tablet Stability
210707_GMP Stability Update
June 30, Top 20 Shareholders
June 30, Top 20 Shareholders
June 28, Phase IIb Dog Cancer Interim Primary Endpoints Attained
210628_CanineInterimClinicalEndpoints
May 31, Top 20 Shareholders
210601_Top_Holders_Report – 2021-06-01T161455.048
May 14, Dr Kim Agnew Appointed PI of MPL Dog Cancer Trial
210514_DrKimAgnewAppointed for Dog Trial
April 30, Top 20 Shareholders
210501_Top_Holders_Report
April 29, Appendix 4C and Quarterly Update
210429_Appendix 4C and Quarterly Update
April 27, Monepantel Phase IIb Dog Lymphoma Interim Plasma Data
210427_PhaseIIb dose update therapeutic window